Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01222234 · ClinicalTrials.gov registry record · NA
Impact of Vitamin D Therapies on Chronic Kidney Disease
A NA study, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT01222234 is a NA study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 56 participants.
The verdict
NCT01222234, a NA study, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
This investigation will consist of a prospective study utilizing two separate populations of patients with 25(OH)D deficiency, one population with chronic kidney disease (CKD) and one with normal renal function.
Interventions
- DRUG Cholecalciferol - CKD
- DEVICE Calcitriol - CKD
- DRUG Cholecalciferol - non-CKD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01222234
The ClinicalTrials.gov registry entry for NCT01222234 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cholecalciferol - CKD is the first listed.
NCT01222234 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01222234 about?
NCT01222234 is a clinical study titled "Impact of Vitamin D Therapies on Chronic Kidney Disease". This investigation will consist of a prospective study utilizing two separate populations of patients with 25(OH)D deficiency, one population with chronic kidney disease (CKD) and one with normal renal function.
What is the current status of trial NCT01222234?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2010-10. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01222234?
The interventions under investigation include: Cholecalciferol - CKD (DRUG), Calcitriol - CKD (DEVICE), Cholecalciferol - non-CKD (DRUG).
Who is sponsoring clinical trial NCT01222234?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.